PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer

Moor, A E; Guevara, C; Altermatt, H J; Warth, R; Jaggi, R; Aebi, S (2011). PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer. Pathobiology, 78(3), pp. 140-8. Basel: Karger 10.1159/000323809

Full text not available from this repository. (Request a copy)

Clinicopathological and molecular factors determine the prognosis of breast cancer. PRO_10 is a prognostic score based on quantitative RT-PCR of 10 proliferation-associated genes obtained from formalin-fixed, paraffin-embedded breast cancer tissues. We revalidated PRO_10 in patients treated in a non-trial setting.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Forschungsbereich Pathologie > Forschungsgruppe Molekularbiologie
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Jaggi, Rolf and Aebi, Stefan

ISSN:

1015-2008

Publisher:

Karger

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:21

Last Modified:

06 Dec 2013 13:27

Publisher DOI:

10.1159/000323809

PubMed ID:

21613801

Web of Science ID:

000292410900003

URI:

https://boris.unibe.ch/id/eprint/7002 (FactScience: 212137)

Actions (login required)

Edit item Edit item
Provide Feedback